PROK1 and pancreatic ductal adenocarcinoma: Our findings demonstrated that low expression of PROK1 in PCa is significantly linked to poor prognosis33, aligning with its role in other malignancies such as pancreatic ductal carcinoma and neuroblastoma50–52, where PROK1 expression correlates with tumor progression and metastasis.